Piper Sandler analyst Matthew O’Brien reiterated a Hold rating on Cutera (CUTR – Research Report) today and set a price target of $18.00. The company’s shares closed yesterday at $17.27.
According to TipRanks, O’Brien is a 4-star analyst with an average return of 5.4% and a 51.30% success rate. O’Brien covers the Healthcare sector, focusing on stocks such as Glaukos, Sight Sciences, and Boston Scientific.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Cutera with a $29.00 average price target.
See Insiders’ Hot Stocks on TipRanks >>
The company has a one-year high of $54.04 and a one-year low of $13.21. Currently, Cutera has an average volume of 836.3K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cutera, Inc. provides laser and energy-based aesthetic systems for practitioners, which engages in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners. Its products include Enlighten, TruSculpt, Excel HR, Excel V, and Xeo. The company was founded by David A. Gollnick in August 1998 and is headquartered in Brisbane, CA.
Read More on CUTR:
